Pilot study highlights outcome preferences for adolescents with chronic migraine, their parents
June 3rd 2022More than 60% of adolescents felt that it was more important to measure decreases in the frequency and intensity of headaches in terms of severe headaches/spikes rather than total headache days.
First patient treated in adolescent epilepsy trial assessing NeuroPace RNS system
May 17th 2022Since its approval for the treatment of medical refractory epilepsy in 2013, the closed-loop neuromodulation device has had its efficacy and safety confirmed in several pivotal studies and will now be assessed in focal epilepsy in the RESPONSE trial.